TY - JOUR
T1 - Vivekananda Yoga Program for Patients with Advanced Lung Cancer and Their Family Caregivers
AU - Milbury, Kathrin
AU - Mallaiah, Smitha
AU - Lopez, Gabriel
AU - Liao, Zhongxing
AU - Yang, Chunyi
AU - Carmack, Cindy
AU - Chaoul, Alejandro
AU - Spelman, Amy
AU - Cohen, Lorenzo
N1 - Publisher Copyright:
© SAGE Publications.
PY - 2015/9/18
Y1 - 2015/9/18
N2 - Background. The primary purpose of this study was to establish the feasibility of a couple-based Vivekananda Yoga (VKC) intervention in lung cancer patients and caregivers. Secondly, we examined preliminary efficacy regarding quality of life (QOL) outcomes. Method. In this single-arm feasibility trial, patients with lung cancer undergoing radiotherapy and their caregivers participated in a 15-session VKC program that focused on the interconnectedness of the dyad. We assessed pre-and post-intervention levels of fatigue, sleep disturbances, psychological distress, overall QOL, spirituality, and relational closeness. We tracked feasibility data, and participants completed program evaluations. Results. We approached 28 eligible dyads of which 15 (53%) consented and 9 (60%) completed the intervention. Patients (mean age = 73 years, 63% female, all stage III) and caregivers (mean age = 62 years, 38% female, 63% spouses) completed a mean of 10 sessions and 95.5% of them rated the program as very useful. Paired t tests revealed a significant increase in patients mental health (d = 0.84; P =.04) and a significant decrease in caregivers sleep disturbances (d = 1.44; P =.02). Although not statistically significant, for patients, effect sizes for change scores were medium for benefit finding and small for distress (d = 0.65 and 0.37, respectively). For caregivers, medium effects were found for improvement in physical functioning (d = 0.50). Conclusion. This novel supportive care program appears to be safe, feasible, acceptable, and subjectively useful for lung cancer patients and their caregivers and lends support for further study.
AB - Background. The primary purpose of this study was to establish the feasibility of a couple-based Vivekananda Yoga (VKC) intervention in lung cancer patients and caregivers. Secondly, we examined preliminary efficacy regarding quality of life (QOL) outcomes. Method. In this single-arm feasibility trial, patients with lung cancer undergoing radiotherapy and their caregivers participated in a 15-session VKC program that focused on the interconnectedness of the dyad. We assessed pre-and post-intervention levels of fatigue, sleep disturbances, psychological distress, overall QOL, spirituality, and relational closeness. We tracked feasibility data, and participants completed program evaluations. Results. We approached 28 eligible dyads of which 15 (53%) consented and 9 (60%) completed the intervention. Patients (mean age = 73 years, 63% female, all stage III) and caregivers (mean age = 62 years, 38% female, 63% spouses) completed a mean of 10 sessions and 95.5% of them rated the program as very useful. Paired t tests revealed a significant increase in patients mental health (d = 0.84; P =.04) and a significant decrease in caregivers sleep disturbances (d = 1.44; P =.02). Although not statistically significant, for patients, effect sizes for change scores were medium for benefit finding and small for distress (d = 0.65 and 0.37, respectively). For caregivers, medium effects were found for improvement in physical functioning (d = 0.50). Conclusion. This novel supportive care program appears to be safe, feasible, acceptable, and subjectively useful for lung cancer patients and their caregivers and lends support for further study.
KW - dyadic intervention
KW - family caregivers
KW - feasibility
KW - mind-body medicine
KW - non-small-cell lung cancer
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=84939544297&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84939544297&partnerID=8YFLogxK
U2 - 10.1177/1534735415583554
DO - 10.1177/1534735415583554
M3 - Article
C2 - 25917816
AN - SCOPUS:84939544297
SN - 1534-7354
VL - 14
SP - 446
EP - 451
JO - Integrative cancer therapies
JF - Integrative cancer therapies
IS - 5
ER -